Bioengineered tissues in wound healing: A progress report

Brian D. Lepow, Michael Downey, Jesse Yurgelon, Lindsey Klassen, David G Armstrong

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

An extensive number of bioengineered tissues have been studied and published in the medical literature. Due to the number of released data for these biologics, the purpose and utility often becomes ambiguous. Despite this difficulty, the therapeutic options continue to be advantageous for the practicing clinicians and can regularly provide manageable outcomes for acute, chronic and difficult-to-heal wounds. The purpose of this article is to review the many biologics that have been studied or released over the past decade and comment on data supporting or refuting their use.

Original languageEnglish (US)
Pages (from-to)255-262
Number of pages8
JournalExpert Review of Dermatology
Volume6
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Biological Products
Wound Healing
Wounds and Injuries
Therapeutics

Keywords

  • bioengineered skin substitutes
  • biologics
  • chronic ulceration
  • diabetes
  • wound care
  • wound healing
  • wounds

ASJC Scopus subject areas

  • Dermatology

Cite this

Bioengineered tissues in wound healing : A progress report. / Lepow, Brian D.; Downey, Michael; Yurgelon, Jesse; Klassen, Lindsey; Armstrong, David G.

In: Expert Review of Dermatology, Vol. 6, No. 3, 06.2011, p. 255-262.

Research output: Contribution to journalArticle

Lepow, Brian D. ; Downey, Michael ; Yurgelon, Jesse ; Klassen, Lindsey ; Armstrong, David G. / Bioengineered tissues in wound healing : A progress report. In: Expert Review of Dermatology. 2011 ; Vol. 6, No. 3. pp. 255-262.
@article{1f3c867b90014ac0b5f0b8abb108e6fa,
title = "Bioengineered tissues in wound healing: A progress report",
abstract = "An extensive number of bioengineered tissues have been studied and published in the medical literature. Due to the number of released data for these biologics, the purpose and utility often becomes ambiguous. Despite this difficulty, the therapeutic options continue to be advantageous for the practicing clinicians and can regularly provide manageable outcomes for acute, chronic and difficult-to-heal wounds. The purpose of this article is to review the many biologics that have been studied or released over the past decade and comment on data supporting or refuting their use.",
keywords = "bioengineered skin substitutes, biologics, chronic ulceration, diabetes, wound care, wound healing, wounds",
author = "Lepow, {Brian D.} and Michael Downey and Jesse Yurgelon and Lindsey Klassen and Armstrong, {David G}",
year = "2011",
month = "6",
doi = "10.1586/edm.11.27",
language = "English (US)",
volume = "6",
pages = "255--262",
journal = "Expert Review of Dermatology",
issn = "1746-9872",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Bioengineered tissues in wound healing

T2 - A progress report

AU - Lepow, Brian D.

AU - Downey, Michael

AU - Yurgelon, Jesse

AU - Klassen, Lindsey

AU - Armstrong, David G

PY - 2011/6

Y1 - 2011/6

N2 - An extensive number of bioengineered tissues have been studied and published in the medical literature. Due to the number of released data for these biologics, the purpose and utility often becomes ambiguous. Despite this difficulty, the therapeutic options continue to be advantageous for the practicing clinicians and can regularly provide manageable outcomes for acute, chronic and difficult-to-heal wounds. The purpose of this article is to review the many biologics that have been studied or released over the past decade and comment on data supporting or refuting their use.

AB - An extensive number of bioengineered tissues have been studied and published in the medical literature. Due to the number of released data for these biologics, the purpose and utility often becomes ambiguous. Despite this difficulty, the therapeutic options continue to be advantageous for the practicing clinicians and can regularly provide manageable outcomes for acute, chronic and difficult-to-heal wounds. The purpose of this article is to review the many biologics that have been studied or released over the past decade and comment on data supporting or refuting their use.

KW - bioengineered skin substitutes

KW - biologics

KW - chronic ulceration

KW - diabetes

KW - wound care

KW - wound healing

KW - wounds

UR - http://www.scopus.com/inward/record.url?scp=79958196443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958196443&partnerID=8YFLogxK

U2 - 10.1586/edm.11.27

DO - 10.1586/edm.11.27

M3 - Article

AN - SCOPUS:79958196443

VL - 6

SP - 255

EP - 262

JO - Expert Review of Dermatology

JF - Expert Review of Dermatology

SN - 1746-9872

IS - 3

ER -